The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned ...

Medtronic Fails at Attempt to Escape Whistleblower Suit Under New Standard, Judge Rules "In sum, although the court previously rejected (and thus did not consider) the application of a but-for ...

That is, if you can handle more volatility.

Medtronic made headlines twice this week. First, the company launched its MiniMed 780G insulin pump system integrated with ...

Medtronic stock has recently seen its fair value price target raised to $109.82 per share, up from $101.13. This change reflects improved analyst sentiment. The upward revision, combined with a ...

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Medtronic's cardiovascular sales rise 10.8% to $3.44 bln CEO emphasizes on cardiology and neuroscience M&A CFO confirms diabetes business to go public in 2026 Nov 18 (Reuters) - Medtronic (MDT.N), ...

Minnesota medtech giant Medtronic found positive momentum Tuesday morning as it faced down what top executives see as a critical moment for the maker of innovative medical devices and procedures for ...

FDA clears Medtronic robot for urologic surgeries, enabling use in prostatectomy, nephrectomy and cystectomy across select U.S. hospitals.

Medtronic plc MDT reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.36, which rose 7.9% from the year-ago quarter’s figure and beat the Zacks Consensus Estimate by 3.82%.